3654 results for «386»
3654 results
Meaningful innovations in interventional cardiology
18 May 2023 – From EuroPCR 2023
In this session, watch the case of a 56-year-old man with HTN, DM, stable CAD, PFO and previous ischaemic stroke, who presented with severely calcified CTO lesion on proximal LAD and significant mid-RCA lesion, and find out how he was treated LIVE... among others!
Redo-TAVI and patient pathway optimisation - Lifetime management decisions today for challenges of the future!
18 May 2023 – From EuroPCR 2023
Watch this session if you want to learn more about the BENCHMARK Registry and its key findings, explore how patients can benefit from optimised TAVI programmes, get an idea of how challenging Redo-TAVI will be for everyday practice in the future, and to view a LIVE...
DCB and scaffolds
16 May 2023 – From EuroPCR 2023
Watch this session to learn about 4 cases, including a patient who underwent successful PTCA with BRS on LAD using the PSP technique, and discuss the best option to consider when choosing between DEB and stents in tricky situations and individual patients.
Contemporary best clinical practice for TAVI
18 May 2023 – From EuroPCR 2023
This interactive session is designed to show how a good pre-procedural assessment can facilitate the planning of a procedure. It also shows how a certain valve can be best suited for patients with certain phenotypes, and finally how to fully optimise the procedure to obtain the...
Complex vascular access for TAVI procedure
16 May 2023 – From EuroPCR 2023
“Application of peripheral endovascular technology in TAVI”, “TAVI with novel device, concomitant aortic aneurysm repair and outcomes”, “Path for glory is calcified and tortuous” are a few of the cases featured in this session. Tune in to gain a comprehensive insight into effective management strategies for...
Left main and complex bifurcation stenting
18 May 2023 – From EuroPCR 2023
Want more training on bifurcation stenting? Learn from the case of this 75-year-old active man, a retired engineer, suffering from effort angina CCS 3 for 6 months, referred to the centre by his cardiologist for a coronary CT scan. He is a former smoker, has a...
Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)
18 May 2023 – From EuroPCR 2023
Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.
More pulses to take you further across all calcium morphologies
17 May 2023 – From EuroPCR 2023
Discover the latest insights on intravascular lithotripsy (IVL) for treating calcified lesions: explore its mechanism of action, technological advancements, and practical tips for challenging cases, including diffuse lesions, left main bifurcations, and eccentric/calcified nodules. Enhance your expertise in IVL with this concise and informative session!
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.
Author
Author
Fractional flow reserve-guided complete or culprit-only PCI in patients with ST-elevation myocardial Infarction - FULL REVASC
08 Apr 2024
Nicola Ryan provides her take on the FULL REVASC trial which was presented at ACC.24 in Atlanta and published Simultaneously in NEJM.
The FULL REVASC trial is a multicentre registry-based randomised control trial comparing FFR-guided complete revascularisation of non-culprit lesions versus culprit lesion PCI alone in patients presenting...
Author
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease
02 Sep 2025
Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.
Author
